Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.
Mosele MF, Westphalen CB, Stenzinger A, Barlesi F, Bayle A, Bièche I, Bonastre J, Castro E, Dienstmann R, Krämer A, Czarnecka AM, Meric-Bernstam F, Michiels S, Miller R, Normanno N, Reis-Filho J, Remon J, Robson M, Rouleau E, Scarpa A, Serrano C, Mateo J, André F. Mosele MF, et al. Among authors: scarpa a. Ann Oncol. 2024 Jul;35(7):588-606. doi: 10.1016/j.annonc.2024.04.005. Epub 2024 May 27. Ann Oncol. 2024. PMID: 38834388 Free article.
Fusion genes in pancreatic tumors.
Gkountakos A, Singhi AD, Westphalen CB, Scarpa A, Luchini C. Gkountakos A, et al. Among authors: scarpa a. Trends Cancer. 2024 May;10(5):430-443. doi: 10.1016/j.trecan.2024.01.009. Epub 2024 Feb 19. Trends Cancer. 2024. PMID: 38378317 Free article. Review.
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets.
Alors-Pérez E, Blázquez-Encinas R, Moreno-Montilla MT, García-Vioque V, Jiménez-Vacas JM, Mafficini A, González-Borja I, Luchini C, Sánchez-Hidalgo JM, Sánchez-Frías ME, Pedraza-Arevalo S, Romero-Ruiz A, Lawlor RT, Viúdez A, Gahete MD, Scarpa A, Arjona-Sánchez Á, Luque RM, Ibáñez-Costa A, Castaño JP. Alors-Pérez E, et al. Among authors: scarpa a. Mol Oncol. 2024 Oct;18(10):2524-2540. doi: 10.1002/1878-0261.13658. Epub 2024 May 24. Mol Oncol. 2024. PMID: 38790138 Free PMC article.
Reappraising the Role of Intraoperative Neck Margin Revision in Post-Neoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis.
Malleo G, Lionetto G, Crippa S, Qadan M, Moser G, Belfiori G, Scarpa A, Schiavo-Lena M, Casciani F, Mattiolo P, Paiella S, Esposito A, Luchini C, Ferrone CR, Lillemoe KD, Fernández-Del Castillo C, Falconi M, Salvia R. Malleo G, et al. Among authors: scarpa a. Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006322. Online ahead of print. Ann Surg. 2024. PMID: 38708617
Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols.
Eren OC, Bagci P, Balci S, Ohike N, Saka B, Sokmensuer C, Leblebici CB, Xue Y, Reid MD, Krasinskas AM, Kooby D, Maithel SK, Sarmiento J, Cheng JD, Taskin OC, Kapran Y, Tarcan ZC, Luchini C, Scarpa A, Basturk O, Adsay NV. Eren OC, et al. Among authors: scarpa a. Ann Surg Oncol. 2024 Oct;31(10):7001-7011. doi: 10.1245/s10434-024-15632-y. Epub 2024 Jul 2. Ann Surg Oncol. 2024. PMID: 38955993 Free PMC article.
Morphologic Characterization of Pancreatic Ductal Adenocarcinoma following Post-neoadjuvant Pancreatectomy and Clinical value of Intratumor Heterogeneity.
Lionetto G, Mattiolo P, Ciulla C, Savegnago G, Casciani F, De Pastena M, Paiella S, Pea A, Esposito A, Crovetto A, Donadelli M, Franzina C, Fassan M, Scarpa A, Salvia R, Malleo G, Luchini C. Lionetto G, et al. Among authors: scarpa a. Ann Surg. 2024 Oct 15. doi: 10.1097/SLA.0000000000006565. Online ahead of print. Ann Surg. 2024. PMID: 39403801
1,303 results